{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T04:36:24Z","timestamp":1725683784045},"reference-count":72,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.pcl.2008.07.002","type":"journal-article","created":{"date-parts":[[2008,10,16]],"date-time":"2008-10-16T08:54:27Z","timestamp":1224147267000},"page":"1227-1240","source":"Crossref","is-referenced-by-count":14,"title":["Use of Psychotropic Medications in Children with Developmental Disabilities"],"prefix":"10.1016","volume":"55","author":[{"suffix":"Jr.","given":"Joseph L.","family":"Calles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pcl.2008.07.002_bib1","first-page":"101","article-title":"Undiagnosed edical conditions and medication side effects presenting as behavioral\/psychiatric problems in people with mental retardation","volume":"4","author":"Kastner","year":"2001","journal-title":"Mental Health Aspects of Developmental Disabilities"},{"issue":"3","key":"10.1016\/j.pcl.2008.07.002_bib2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1352\/0895-8017(2005)110<164:MABSAP>2.0.CO;2","article-title":"Medical and behavioral symptoms as potential medication side effects in adults with developmental disabilities","volume":"110","author":"Valdovinos","year":"2005","journal-title":"Am J\u00a0Ment Retard"},{"issue":"3","key":"10.1016\/j.pcl.2008.07.002_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1352\/0895-8017(2001)106<0231:POMRAD>2.0.CO;2","article-title":"Prevalence of mental retardation and developmental disabilities: Estimates from the 1994\/1995 National Health Interview Survey Disability Supplements","volume":"106","author":"Larson","year":"2001","journal-title":"Am J Ment Retard"},{"key":"10.1016\/j.pcl.2008.07.002_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.publhealth.28.021406.144007","article-title":"The epidemiology of autism spectrum disorders","volume":"28","author":"Newschaffer","year":"2007","journal-title":"Annu Rev Public Health"},{"issue":"10","key":"10.1016\/j.pcl.2008.07.002_bib5","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1528-1167.2006.00633.x","article-title":"Epilepsy in North America: a report prepared under the auspices of the Global Campaign Against Epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization","volume":"47","author":"Theodore","year":"2006","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.pcl.2008.07.002_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00023210-200013020-00005","article-title":"Epidemiology and treatment of epilepsy in patients who are mentally retarded","volume":"13","author":"Deb","year":"2000","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.pcl.2008.07.002_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/13269780050033562","article-title":"Stress, behaviour, and sleep problems in children with an intellectual disability","volume":"25","author":"Richdale","year":"2000","journal-title":"J Intellect Dev Disabil"},{"issue":"5","key":"10.1016\/j.pcl.2008.07.002_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0891-4222(97)00016-4","article-title":"Psychopathology in children and adolescents with developmental disorders","volume":"18","author":"Hardan","year":"1997","journal-title":"Res Dev Disabil"},{"issue":"3","key":"10.1016\/j.pcl.2008.07.002_bib9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1469-7610.2004.00250.x","article-title":"Conduct disorder and oppositional defiant disorder in a national sample: developmental epidemiology","volume":"45","author":"Maughan","year":"2004","journal-title":"J Child Psychol Psychiatry"},{"issue":"9","key":"10.1016\/j.pcl.2008.07.002_bib10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archpedi.161.9.857","article-title":"Prevalence, recognition, and treatment of attention-deficit\/hyperactivity disorder in a national sample of US children","volume":"161","author":"Froehlich","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"9495","key":"10.1016\/j.pcl.2008.07.002_bib11","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0140-6736(05)67600-3","article-title":"Self-harm","volume":"366","author":"Skegg","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pcl.2008.07.002_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ab.20164","article-title":"Age differences in the prevalence of physical aggression among 5\u201311-year-old Canadian boys and girls","volume":"33","author":"Lee","year":"2007","journal-title":"Aggress Behav"},{"key":"10.1016\/j.pcl.2008.07.002_bib13","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000"},{"issue":"1","key":"10.1016\/j.pcl.2008.07.002_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1362361304040638","article-title":"Associated medical disorders and disabilities in children with autistic disorder: a population-based study","volume":"8","author":"Kielinen","year":"2004","journal-title":"Autism"},{"issue":"5","key":"10.1016\/j.pcl.2008.07.002_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.braindev.2006.09.003","article-title":"Childhood autism and associated comorbidities","volume":"29","author":"Zafeiriou","year":"2007","journal-title":"Brain Dev"},{"issue":"2","key":"10.1016\/j.pcl.2008.07.002_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF02172004","article-title":"Brief report: comorbid psychiatric disorders of autistic disorder","volume":"26","author":"Tsai","year":"1996","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"10.1016\/j.pcl.2008.07.002_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0883073807307102","article-title":"Autism spectrum disorders: concurrent clinical disorders","volume":"23","author":"Ming","year":"2008","journal-title":"J Child Neurol"},{"issue":"1","key":"10.1016\/j.pcl.2008.07.002_bib18","first-page":"101","article-title":"Aggression as a symptom of mood destabilization in pervasive developmental disorders","volume":"10","author":"Palucka","year":"2003","journal-title":"J Dev Disabil"},{"issue":"3","key":"10.1016\/j.pcl.2008.07.002_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1023\/A:1025854532079","article-title":"Risperidone and explosive aggressive autism","volume":"27","author":"Horrigan","year":"1997","journal-title":"J Autism Dev Disord"},{"issue":"4","key":"10.1016\/j.pcl.2008.07.002_bib20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/00148581-200709040-00006","article-title":"Atypical antipsychotics in children with pervasive developmental disorders","volume":"9","author":"Chavez","year":"2007","journal-title":"Pediatr Drugs"},{"issue":"5","key":"10.1016\/j.pcl.2008.07.002_bib21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1089\/cap.2006.16.621","article-title":"A prospective, open-label trial of galantamine in autistic disorder","volume":"16","author":"Nicolson","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"Pt 8","key":"10.1016\/j.pcl.2008.07.002_bib22","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1046\/j.1365-2788.2003.00507.x","article-title":"Risk factors for self-injurious behaviours among 222 young children with autistic disorders","volume":"47","author":"Baghdadli","year":"2003","journal-title":"J Intellect Disabil Res"},{"issue":"3","key":"10.1016\/j.pcl.2008.07.002_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1005596502855","article-title":"Varieties of repetitive behaviour in autism: comparisons to mental retardation","volume":"30","author":"Bodfish","year":"2000","journal-title":"J Autism Dev Disord"},{"issue":"3","key":"10.1016\/j.pcl.2008.07.002_bib24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00702-005-0337-x","article-title":"Self injurious behavior in autism: clinical aspects and treatment with risperidone","volume":"113","author":"Canitano","year":"2006","journal-title":"J Neural Transm"},{"issue":"5","key":"10.1016\/j.pcl.2008.07.002_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/0269881105056543","article-title":"Metabolic side effects of atypical antipsychotics in children: a literature review","volume":"19","author":"Fedorowicz","year":"2005","journal-title":"J Psychopharmacol"},{"issue":"23","key":"10.1016\/j.pcl.2008.07.002_bib26","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1056\/NEJMoa031049","article-title":"Obesity and the metabolic syndrome in children and adolescents","volume":"350","author":"Weiss","year":"2004","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.pcl.2008.07.002_bib27","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1345\/aph.1G499","article-title":"Efficacy and safety of naltrexone use in pediatric patients with autistic disorder","volume":"40","author":"Elchaar","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.pcl.2008.07.002_bib28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1089\/cap.2006.16.737","article-title":"Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders","volume":"16","author":"Lee","year":"2006","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"3","key":"10.1016\/j.pcl.2008.07.002_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11126-005-2980-7","article-title":"The use of psychostimulants in pervasive developmental disorders","volume":"76","author":"Abanilla","year":"2005","journal-title":"Psychiatr Q"},{"issue":"10","key":"10.1016\/j.pcl.2008.07.002_bib30","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1097\/01.chi.0000231976.28719.2a","article-title":"Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial","volume":"45","author":"Arnold","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.pcl.2008.07.002_bib31","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/cap.2006.16.611","article-title":"Atomoxetine for attention-deficit\/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot study","volume":"16","author":"Troost","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"5","key":"10.1016\/j.pcl.2008.07.002_bib32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2214.2006.00616.x","article-title":"Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems","volume":"32","author":"Garstang","year":"2006","journal-title":"Child Care Health Dev"},{"issue":"6","key":"10.1016\/j.pcl.2008.07.002_bib33","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10803-006-0116-z","article-title":"An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism","volume":"36","author":"Giannotti","year":"2006","journal-title":"J Autism Dev Disord"},{"issue":"5","key":"10.1016\/j.pcl.2008.07.002_bib34","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1089\/cap.2006.16.631","article-title":"Ramelteon for insomnia in two youths with autistic disorder","volume":"16","author":"Stigler","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"10.1016\/j.pcl.2008.07.002_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1362361300004002002","article-title":"The prevalence of anxiety and mood problems among children with autism and Asperger syndrome","volume":"4","author":"Kim","year":"2000","journal-title":"Autism"},{"issue":"1","key":"10.1016\/j.pcl.2008.07.002_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1362361306062013","article-title":"Presentation of depression in autism and Asperger syndrome. A review","volume":"10","author":"Stewart","year":"2006","journal-title":"Autism"},{"issue":"2","key":"10.1016\/j.pcl.2008.07.002_bib37","first-page":"123","article-title":"Epilepsy and developmental disability part I: developmental disorders in which epilepsy may be comorbid","volume":"10","author":"Persad","year":"2003","journal-title":"Journal on Developmental Disabilities"},{"issue":"5","key":"10.1016\/j.pcl.2008.07.002_bib38","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1023\/A:1005572128200","article-title":"Treatment of seizure disorders and EEG abnormalities in children with autism spectrum disorders","volume":"30","author":"Tuchman","year":"2000","journal-title":"J Autism Dev Disord"},{"issue":"Suppl 2","key":"10.1016\/j.pcl.2008.07.002_bib39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1528-1167.2006.00684.x","article-title":"Effects of antiepileptic drugs on mood and behavior","volume":"47","author":"Schmitz","year":"2006","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.pcl.2008.07.002_bib40","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/01.GIM.0000182468.22666.dd","article-title":"American College of Medical Genetics Practice Guideline: fragile X syndrome: diagnostic and carrier testing","volume":"7","author":"Sherman","year":"2005","journal-title":"Genet Med"},{"issue":"5","key":"10.1016\/j.pcl.2008.07.002_bib41","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/000992280504400501","article-title":"Fragile X syndrome: an update and review for the primary pediatrician","volume":"44","author":"Visootsak","year":"2005","journal-title":"Clin Pediatr (Phila)"},{"issue":"2","key":"10.1016\/j.pcl.2008.07.002_bib42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ajmg.a.10078","article-title":"Self-injurious behavior in young boys with fragile X syndrome","volume":"118","author":"Symons","year":"2003","journal-title":"Am J Med Genet"},{"issue":"21","key":"10.1016\/j.pcl.2008.07.002_bib43","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/ajmg.a.31388","article-title":"ADHD symptoms in children with FXS","volume":"140","author":"Sullivan","year":"2006","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1016\/j.pcl.2008.07.002_bib44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mrdd.20007","article-title":"Psychopharmacology in fragile X syndrome\u2014present and future","volume":"10","author":"Berry-Kravis","year":"2004","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"1\u20132","key":"10.1016\/j.pcl.2008.07.002_bib45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ajmg.1320430119","article-title":"Sleep apnea in fragile X syndrome","volume":"43","author":"Tirosh","year":"1992","journal-title":"Am J Med Genet"},{"issue":"2","key":"10.1016\/j.pcl.2008.07.002_bib46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1542\/peds.91.2.321","article-title":"Psychiatric disorders associated with fragile X in the young female","volume":"91","author":"Freund","year":"1993","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.pcl.2008.07.002_bib47","doi-asserted-by":"crossref","first-page":"E88","DOI":"10.1542\/peds.108.5.e88","article-title":"The influence of environmental and genetic factors on behavior problems and autistic symptoms in boys and girls with fragile X syndrome","volume":"108","author":"Hessl","year":"2001","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.pcl.2008.07.002_bib48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0006-3223(93)90143-2","article-title":"Bipolar spectrum disorder and fragile X syndrome: a family study","volume":"33","author":"Jeffries","year":"1993","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.pcl.2008.07.002_bib49","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-2788.2006.00899.x","article-title":"Behavioural equivalents of anxiety in children with fragile X syndrome: parent and teacher report","volume":"51","author":"Sullivan","year":"2007","journal-title":"J Intellect Disabil Res"},{"issue":"11","key":"10.1016\/j.pcl.2008.07.002_bib50","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2165\/00023210-200418110-00001","article-title":"Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy","volume":"18","author":"Tsiouris","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pcl.2008.07.002_bib51","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/ajmg.a.31286","article-title":"Autistic behavior in children with fragile X syndrome: prevalence, stability, and the impact of FMRP","volume":"140A","author":"Hatton","year":"2006","journal-title":"Am J Med Genet A"},{"issue":"11","key":"10.1016\/j.pcl.2008.07.002_bib52","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1469-8749.2002.tb00277.x","article-title":"Epilepsy in fragile X syndrome","volume":"44","author":"Berry-Kravis","year":"2002","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.pcl.2008.07.002_bib53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1542\/peds.2004-0259","article-title":"A practical clinical approach to diagnosis of fetal alcohol spectrum disorders: clarification of the 1996 Institute of Medicine Criteria","volume":"115","author":"Hoyme","year":"2005","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.pcl.2008.07.002_bib54","first-page":"159","article-title":"Estimating the prevalence of fetal alcohol syndrome. A\u00a0summary","volume":"25","author":"May","year":"2001","journal-title":"Alcohol Res Health"},{"key":"10.1016\/j.pcl.2008.07.002_bib55","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ntt.2003.07.014","article-title":"Fetal alcohol syndrome: neuropsychiatric phenomics","volume":"25","author":"Burd","year":"2003","journal-title":"Neurotoxicol Teratol"},{"issue":"4","key":"10.1016\/j.pcl.2008.07.002_bib56","doi-asserted-by":"crossref","first-page":"545","DOI":"10.15288\/jsa.2005.66.545","article-title":"Moral maturity and delinquency after prenatal alcohol exposure","volume":"66","author":"Schonfeld","year":"2005","journal-title":"J Stud Alcohol"},{"key":"10.1016\/j.pcl.2008.07.002_bib57","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1098-2779(1999)5:4<305::AID-MRDD8>3.0.CO;2-L","article-title":"Psychopharmacological interventions in fragile X syndrome, fetal alcohol syndrome, Prader-Willi syndrome, Angelman syndrome, Smith-Magenis syndrome, and velocardiofacial syndrome","volume":"5","author":"Hagerman","year":"1999","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"3","key":"10.1016\/j.pcl.2008.07.002_bib58","first-page":"211","article-title":"Fetal alcohol syndrome and its long-term effects","volume":"58","author":"Merrick","year":"2006","journal-title":"Minerva Pediatr"},{"issue":"2","key":"10.1016\/j.pcl.2008.07.002_bib59","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1530-0277.1998.tb03657.x","article-title":"Long-term outcome of children with fetal alcohol syndrome: psychopathology, behavior, and intelligence","volume":"22","author":"Steinhausen","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.pcl.2008.07.002_bib60","first-page":"90","article-title":"Psychostimulant clinical response in fetal alcohol syndrome","volume":"45","author":"O'Malley","year":"2000","journal-title":"Can J Psychiatry"},{"issue":"3","key":"10.1016\/j.pcl.2008.07.002_bib61","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/1087054705283880","article-title":"Association of attention deficit hyperactivity disorder and gestational alcohol exposure: an exploratory study","volume":"9","author":"Bhatara","year":"2006","journal-title":"J Atten Disord"},{"issue":"5","key":"10.1016\/j.pcl.2008.07.002_bib62","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00004583-199605000-00014","article-title":"Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases","volume":"35","author":"Prince","year":"1996","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.pcl.2008.07.002_bib63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00787-005-0424-4","article-title":"The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders: a case series","volume":"14","author":"Ingrassia","year":"2005","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.pcl.2008.07.002_bib64","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1469-8749.2004.tb00998.x","article-title":"Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment","volume":"46","author":"Phillips","year":"2004","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"10.1016\/j.pcl.2008.07.002_bib65","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1081\/ADA-120015880","article-title":"Psychiatric illness in a clinical sample of children with prenatal alcohol exposure","volume":"28","author":"O'Connor","year":"2002","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"6","key":"10.1016\/j.pcl.2008.07.002_bib66","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/chi.0b013e31804a859b","article-title":"Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder","volume":"46","author":"Hughes","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"10.1016\/j.pcl.2008.07.002_bib67","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00004583-200503000-00006","article-title":"Treatment guidelines for children and adolescents with bipolar disorder","volume":"44","author":"Kowatch","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"10.1016\/j.pcl.2008.07.002_bib68","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1530-0277.1999.tb04227.x","article-title":"Behavioral and psychosocial profiles of alcohol-exposed children","volume":"23","author":"Roebuck","year":"1999","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"10.1016\/j.pcl.2008.07.002_bib69","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1176\/ajp.155.4.552","article-title":"Mental illness in adults with fetal alcohol syndrome or fetal alcohol effects","volume":"155","author":"Famy","year":"1998","journal-title":"Am J Psychiatry"},{"issue":"Suppl 7","key":"10.1016\/j.pcl.2008.07.002_bib70","first-page":"4S","article-title":"Practice parameter for the assessment and treatment of children and adolescents with schizophrenia","volume":"40","author":"American Academy of Child and Adolescent Psychiatry","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.pcl.2008.07.002_bib71","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/archpsyc.60.4.377","article-title":"A 21-year longitudinal analysis of the effects of prenatal alcohol exposure on young adult drinking","volume":"60","author":"Baer","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"10.1016\/j.pcl.2008.07.002_bib72","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/01.chi.0000159135.33706.37","article-title":"Practice parameter for the assessment and treatment of children and adolescents with substance use disorders","volume":"44","author":"American Academy of Child and Adolescent Psychiatry","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395508001508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395508001508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T14:04:56Z","timestamp":1684591496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395508001508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0031395508001508"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2008.07.002","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}